Nelarabrine
novartis
['bet', 'leusm']
this cut rate of hct in cr1 from 40 to 21% in pts &lt;age 45! graall-14 de-intensified chemotx for pts age 45-59 -&gt; less death in cr though more relapse. os better in graall-2014 cohort in all age groups, likely in part due to better outcomes post-relapse. #leusm #ash22 #allsm (2/2)
Leukemia/cell therapy doc & AYA Leukemia Program Leader at @MSKCancerCenter w/ special interest in ALL. Indie rock & Boston sports fan. Opinions=my own.??????